Table 2

Odds ratios for co-prescription of anti-diabetes agents and mood stabilizers.

Total


Male

Female


Drugs

OR

CI (95%)

OR

CI (95%)

OR

Cl (95%)


Lamotrigine and insulin

1.8

(1.3, 2.5)

1.8

(1.3, 2.4)

1.7

(1.3, 2.1)

Carbamazepine and insulin

2.0

(1.3, 3.2)

3.0

(1.9, 4.8)

2.4

(1.8, 3.4)

Lithium and insulin

1.4

(1.0, 1.9)

1.6

(1.1, 2.2)

1.4

(1.1, 1.8)

Valproate and insulin

1.6

(1.1, 2.3)

2.6

(1.8, 3.7)

2.0

(1.5, 2.6)


Lamotrigine and oral antidiabetics

1.3

(1.0, 1.7)

1.8

(1.5, 2.3)

1.6

(1.3, 1.9)

Carbamazepine and oral antidiabetics

1.8

(1.3, 2.5)

2.6

(1.8, 3.6)

2.1

(1.7, 2.7)

Lithium and oral antidiabetics

1.5

(1.2, 1.8)

2.6

(2.2, 3.0)

1.9

(1.7, 2.2)

Valproate and oral antidiabetics

2.4

(1.9, 3.0)

3.0

(2.3, 3.7)

2.6

(2.2, 3.1)


Odds ratios, with 95% CI, for using different mood stabilizers, combined or in in monotherapy for persons using anti-diabetes agents in monotherapy compared to the non diabetic population (divided into genders).

Svendal et al. BMC Medicine 2012 10:148   doi:10.1186/1741-7015-10-148

Open Data